Researchers analyzed the medical records of more than 3,000 breast cancer patients who received care at the New York City-based health system’s Perlmutter Cancer Center from February to May 2020. They compared those who received cytotoxic, or cell-killing, chemotherapy, which can weaken the body’s immune system, to those who received other cancer drugs.
Just 2 percent of patients, or 64 people, became infected with COVID-19. Of those, 10 died, which researchers said was expected, regardless of cancer, indicating that breast cancer treatment did not raise the risk of dying from COVID-19.
“Our results show that patients can safely receive breast cancer therapy, including chemotherapy, during the pandemic,” said Douglas Marks, MD, lead study investigator and medical oncologist at Perlmutter Cancer Center.
Leave a Reply